PubRank

Gary K Steinberg

Author PubWeight™ 164.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A 2012 4.20
2 Arteriovenous malformations. Lancet 2002 3.15
3 Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 2005 2.87
4 Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 2005 2.53
5 Interrupting reperfusion as a stroke therapy: ischemic postconditioning reduces infarct size after focal ischemia in rats. J Cereb Blood Flow Metab 2006 2.41
6 Cell transplantation therapy for stroke. Stroke 2007 2.30
7 Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 2011 2.27
8 Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 2006 2.17
9 Sex differences in clinical presentation and treatment outcomes in Moyamoya disease. Neurosurgery 2012 2.06
10 Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci U S A 2007 2.03
11 Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet 2008 1.95
12 Moyamoya disease in pediatric patients: outcomes of neurosurgical interventions. Neurosurg Focus 2008 1.84
13 Protein kinase C delta mediates cerebral reperfusion injury in vivo. J Neurosci 2004 1.71
14 Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem 2003 1.69
15 Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2009 1.61
16 Who's in favor of translational cell therapy for stroke: STEPS forward please? Cell Transplant 2009 1.60
17 Thrombospondins 1 and 2 are necessary for synaptic plasticity and functional recovery after stroke. J Cereb Blood Flow Metab 2008 1.59
18 Multimodality treatment of posterior fossa arteriovenous malformations. J Neurosurg 2008 1.59
19 General versus specific actions of mild-moderate hypothermia in attenuating cerebral ischemic damage. J Cereb Blood Flow Metab 2007 1.57
20 The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J Neurochem 2008 1.54
21 Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke 2005 1.54
22 Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 2011 1.54
23 Spinal pilocytic astrocytoma in an elderly patient. World Neurosurg 2011 1.49
24 Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke 2010 1.44
25 Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis 2006 1.40
26 Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One 2008 1.37
27 Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology 2014 1.36
28 Bcl-2 transfection via herpes simplex virus blocks apoptosis-inducing factor translocation after focal ischemia in the rat. J Cereb Blood Flow Metab 2004 1.36
29 Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article. J Neurosurg 2009 1.35
30 Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease. Stroke 2011 1.34
31 Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther 2009 1.34
32 Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci U S A 2011 1.32
33 Patients beware: commercialized stem cell treatments on the web. Cell Stem Cell 2010 1.32
34 Aneurysmal subarachnoid hemorrhage in patients with Hunt and Hess grade 4 or 5: treatment using the Guglielmi detachable coil system. AJNR Am J Neuroradiol 2003 1.27
35 Mild hypothermia reduces apoptosis of mouse neurons in vitro early in the cascade. J Cereb Blood Flow Metab 2002 1.21
36 Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol 2005 1.20
37 Suppression of deltaPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J Cereb Blood Flow Metab 2007 1.17
38 Paradoxical cerebral herniation secondary to lumbar puncture after decompressive craniectomy for a large space-occupying hemispheric stroke: case report. Neurosurgery 2005 1.16
39 Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods 2011 1.16
40 New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya. Curr Neurovasc Res 2006 1.14
41 Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med 2008 1.13
42 Gene transfer of HSP72 protects cornu ammonis 1 region of the hippocampus neurons from global ischemia: influence of Bcl-2. Ann Neurol 2002 1.12
43 Biphasic cytochrome c release after transient global ischemia and its inhibition by hypothermia. J Cereb Blood Flow Metab 2005 1.12
44 DeltaPKC mediates microcerebrovascular dysfunction in acute ischemia and in chronic hypertensive stress in vivo. Brain Res 2007 1.11
45 Efficacy of endovascular stenting in dural venous sinus stenosis for the treatment of idiopathic intracranial hypertension. Neurosurg Focus 2009 1.10
46 Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery 2003 1.10
47 Evaluation of surgical techniques for neuronal cell transplantation used in patients with stroke. Cell Transplant 2004 1.09
48 Deep arteriovenous malformations of the basal ganglia and thalamus: natural history. J Neurosurg 2003 1.08
49 Intravascular cell replacement therapy for stroke. Neurosurg Focus 2008 1.07
50 Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods 2008 1.06
51 Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol 2013 1.05
52 The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke 2011 1.05
53 Surgical and endovascular management of symptomatic posterior circulation fusiform aneurysms. J Neurosurg 2007 1.05
54 Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia. Exp Neurol 2004 1.04
55 Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery 2008 1.04
56 Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther 2011 1.04
57 epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury. Neurosci Lett 2008 1.04
58 Pathophysiology and genetic factors in moyamoya disease. Neurosurg Focus 2009 1.04
59 Neurocognitive impairment in adults with moyamoya disease without stroke. Neurosurgery 2012 1.03
60 Cavernous malformation of brainstem, thalamus, and basal ganglia: a series of 176 patients. Neurosurgery 2013 1.03
61 Conditions of protection by hypothermia and effects on apoptotic pathways in a rat model of permanent middle cerebral artery occlusion. J Neurosurg 2007 1.03
62 Effects of mild hypothermia on superoxide anion production, superoxide dismutase expression, and activity following transient focal cerebral ischemia. Neurobiol Dis 2002 1.02
63 Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. PLoS One 2012 1.02
64 Neurosurgical advances in the treatment of moyamoya disease. Stroke 2011 1.02
65 Assessment of outcome following decompressive craniectomy for malignant middle cerebral artery infarction in patients older than 60 years of age. Neurosurg Focus 2009 1.01
66 Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia. J Cereb Blood Flow Metab 2008 1.00
67 Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet 2011 0.99
68 Positron emission tomography imaging of poststroke angiogenesis. Stroke 2008 0.99
69 Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke 2012 0.99
70 Patients with moyamoya disease presenting with movement disorder. J Neurosurg Pediatr 2010 0.99
71 FasL shedding is reduced by hypothermia in experimental stroke. J Neurochem 2008 0.99
72 Functional engraftment of the medial ganglionic eminence cells in experimental stroke model. Cell Transplant 2009 0.98
73 Epsilon PKC may contribute to the protective effect of hypothermia in a rat focal cerebral ischemia model. Stroke 2007 0.98
74 Potential of adult neural stem cells in stroke therapy. Regen Med 2008 0.98
75 Mild postischemic hypothermia prolongs the time window for gene therapy by inhibiting cytochrome C release. Stroke 2004 0.97
76 Quantitative hemodynamic studies in moyamoya disease: a review. Neurosurg Focus 2009 0.97
77 Proteomic biomarker discovery in cerebrospinal fluid for cerebral vasospasm following subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 2010 0.96
78 Mild hypothermia attenuates cytochrome c release but does not alter Bcl-2 expression or caspase activation after experimental stroke. J Cereb Blood Flow Metab 2002 0.96
79 Hypothermia blocks beta-catenin degradation after focal ischemia in rats. Brain Res 2008 0.96
80 Imaging neural stem cell graft-induced structural repair in stroke. Cell Transplant 2013 0.94
81 Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage. Pituitary 2009 0.92
82 Hemorrhage rate in patients with Spetzler-Martin grades IV and V arteriovenous malformations: is treatment justified? Stroke 2006 0.91
83 Stem cell therapy for acute cerebral injury: what do we know and what will the future bring? Curr Opin Neurol 2013 0.91
84 Revascularization of the posterior circulation. Skull Base 2005 0.91
85 Progressive cerebral vascular degeneration with mitochondrial encephalopathy. Am J Med Genet A 2008 0.91
86 Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype. Am J Med Genet A 2010 0.91
87 Management of pediatric intracranial arteriovenous malformations: experience with multimodality therapy. Neurosurgery 2011 0.91
88 Predictors of clinical and angiographic outcome after surgical or endovascular therapy of very large and giant intracranial aneurysms. Neurosurgery 2011 0.90
89 Morphologic assessment of middle cerebral artery aneurysms for endovascular treatment. J Stroke Cerebrovasc Dis 2007 0.90
90 Prokineticin 2 is an endangering mediator of cerebral ischemic injury. Proc Natl Acad Sci U S A 2012 0.90
91 Gene expression profiling of blood in brain arteriovenous malformation patients. Transl Stroke Res 2011 0.90
92 Surgical management of posterior fossa arteriovenous malformations. Neurosurgery 2006 0.89
93 Cerebral proliferative angiopathy. J Neurointerv Surg 2011 0.89
94 The protective effect of early hypothermia on PTEN phosphorylation correlates with free radical inhibition in rat stroke. J Cereb Blood Flow Metab 2009 0.89
95 Mutational analysis of 206 families with cavernous malformations. J Neurosurg 2003 0.89
96 Pathogenesis and radiobiology of brain arteriovenous malformations: implications for risk stratification in natural history and posttreatment course. Neurosurg Focus 2009 0.89
97 Catalase over-expression protects striatal neurons from transient focal cerebral ischemia. Neuroreport 2004 0.89
98 Failure of primary percutaneous angioplasty and stenting in the prevention of ischemia in Moyamoya angiopathy. Cerebrovasc Dis 2010 0.89
99 National trends in spinal arteriovenous malformations. Neurosurg Focus 2009 0.88
100 Cellular and molecular events underlying ischemia-induced neuronal apoptosis. Drug News Perspect 2003 0.88
101 Gene therapy using SOD1 protects striatal neurons from experimental stroke. Neurosci Lett 2006 0.87
102 Attenuation of nitric oxide synthase isoform expression by mild hypothermia after focal cerebral ischemia: variations depending on timing of cooling. J Neurosurg 2003 0.87
103 The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage. Neurosurg Rev 2012 0.86
104 In vivo neural stem cell imaging: current modalities and future directions. Regen Med 2010 0.85
105 Intraarterial transplantation of human umbilical cord blood mononuclear cells is more efficacious and safer compared with umbilical cord mesenchymal stromal cells in a rodent stroke model. Stem Cell Res Ther 2014 0.85
106 Neurophysiological monitoring in the endovascular therapy of aneurysms. AJNR Am J Neuroradiol 2003 0.85
107 Carotid and vertebral rete mirabile in man presenting with intraparenchymal hemorrhage: a case report. J Stroke Cerebrovasc Dis 2007 0.85
108 The evolution of cerebral revascularization surgery. Neurosurg Focus 2009 0.85
109 Inhibiting caspase-3 activity blocks beta-catenin degradation after focal ischemia in rat. Neuroreport 2008 0.84
110 Gene therapy and hypothermia for stroke treatment. Ann N Y Acad Sci 2003 0.84
111 Cell replacement therapy for intracerebral hemorrhage. Neurosurg Focus 2008 0.84
112 Immune response profiling identifies autoantibodies specific to Moyamoya patients. Orphanet J Rare Dis 2013 0.84
113 Microsurgical management of distal anterior cerebral artery aneurysms: from basic to complex, a video review of four cases. Acta Neurochir (Wien) 2013 0.83
114 Manufacturing neurons from human embryonic stem cells: biological and regulatory aspects to develop a safe cellular product for stroke cell therapy. Regen Med 2009 0.83
115 Tracking stem cells for cellular therapy in stroke. Curr Pharm Des 2012 0.82
116 Multimodality management of Spetzler-Martin Grade III arteriovenous malformations. J Neurosurg 2012 0.82
117 Combined endovascular and microsurgical management of complex cerebral aneurysms. Front Neurol 2013 0.82
118 Clinical neuroproteomics and biomarkers: from basic research to clinical decision making. Neurosurgery 2012 0.81
119 Delayed retraction of the pipeline embolization device and corking failure: pitfalls of pipeline embolization device placement in the setting of a ruptured aneurysm. Neurosurgery 2013 0.81
120 Flexible omnidirectional carbon dioxide laser as an effective tool for resection of brainstem, supratentorial, and intramedullary cavernous malformations. Neurosurgery 2014 0.80
121 Blocking glucocorticoid and enhancing estrogenic genomic signaling protects against cerebral ischemia. J Cereb Blood Flow Metab 2008 0.80
122 The impact of hypopituitarism on function and performance in subjects with recent history of traumatic brain injury and aneurysmal subarachnoid haemorrhage. Brain Inj 2009 0.80
123 Intraoperative blood flow analysis of direct revascularization procedures in patients with moyamoya disease. J Cereb Blood Flow Metab 2010 0.80
124 Outcomes of surgery for resection of regions of symptomatic radiation injury after stereotactic radiosurgery for arteriovenous malformations. Neurosurgery 2006 0.80
125 Results of the prospective, randomized, multicenter clinical trial evaluating a biosynthesized cellulose graft for repair of dural defects. Neurosurgery 2011 0.80
126 Multimodality treatment of giant intracranial arteriovenous malformations. Neurosurgery 2007 0.80
127 Development of arteriovenous fistula after revascularization bypass for Moyamoya disease: case report. Neurosurgery 2015 0.80
128 Safety and performance of a novel intravascular catheter for induction and reversal of hypothermia in a porcine model. Neurosurgery 2002 0.79
129 Moderate hypothermia inhibits brain inflammation and attenuates stroke-induced immunodepression in rats. CNS Neurosci Ther 2013 0.79
130 Cerebral perfusion imaging in vasospasm. Neurosurg Focus 2006 0.79
131 Direct bypass techniques for the treatment of pediatric moyamoya disease. Neurosurg Clin N Am 2010 0.79
132 Derivation of injury-responsive dendritic cells for acute brain targeting and therapeutic protein delivery in the stroke-injured rat. PLoS One 2013 0.79
133 Reflections on the benefits and pitfalls of ultra-early aneurysm treatment after subarachnoid hemorrhage. World Neurosurg 2011 0.78
134 Activating deltaPKC antagonizes the protective effect of ERK1/2 inhibition against stroke in rats. Brain Res 2008 0.78
135 Optogenetic approaches to study stroke recovery. ACS Chem Neurosci 2014 0.78
136 Hypothermia blocks ischemic changes in ubiquitin distribution and levels following stroke. Neuroreport 2006 0.78
137 Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases. Clin Neuropathol 2014 0.77
138 Less invasive pedicled omental-cranial transposition in pediatric patients with moyamoya disease and failed prior revascularization. Neurosurgery 2014 0.76
139 The transition from hunterian ligation to intracranial aneurysm clips: a historical perspective. Neurosurg Focus 2006 0.76
140 Intraoperative hypothermia during vascular neurosurgical procedures. Neurosurg Focus 2009 0.76
141 Lithium treatment reduces brain injury induced by focal ischemia with partial reperfusion and the protective mechanisms dispute the importance of akt activity. Aging Dis 2012 0.76
142 Mild hypothermia decreases GSK3beta expression following global cerebral ischemia. Neurocrit Care 2005 0.76
143 Optogenetic Stimulation of Neural Grafts Enhances Neurotransmission and Downregulates the Inflammatory Response in Experimental Stroke Model. Cell Transplant 2015 0.76
144 Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease? J Neurosurg 2015 0.76
145 An insult-inducible vector system activated by hypoxia and oxidative stress for neuronal gene therapy. Transl Stroke Res 2011 0.76
146 Clip reconstruction of midbasilar aneurysms. World Neurosurg 2012 0.75
147 CGS 19755 (Selfotel): A Novel Neuroprotective Agent Against CNS Injury. CNS Drug Rev 1996 0.75
148 Headaches in children with moyamoya disease: does revascularization help? World Neurosurg 2012 0.75
149 In reply. The genetics of moyamoya disease: recent insights into the pathogenesis of the disease. Neurosurgery 2013 0.75
150 Subarachnoid hemorrhage. Handb Clin Neurol 2009 0.75
151 Characterization of the integrin alpha v beta3 in arteriovenous malformations and cavernous malformations. Cerebrovasc Dis 2005 0.75
152 Surgical Therapy. Front Neurol Neurosci 2016 0.75
153 Study of systemic cooling in acute spinal cord injury. Neurosurgery 2010 0.75
154 Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article. J Neurosurg 2011 0.75
155 Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features. Radiology 2015 0.75
156 A simplified method for administration of intra-arterial nicardipine for vasospasm with cervical catheter infusion. Neurosurgery 2012 0.75
157 Prospects for the treatment of stroke using gene therapy. Expert Rev Neurother 2003 0.75
158 Cerebrospinal Proteomic Analysis after Aneurysmal Subarachnoid Hemorrhage: The Role of New Biomarkers: 934. Neurosurgery 2009 0.75
159 Visual field preservation after curative multi-modality treatment of occipital lobe arteriovenous malformations. Neurosurgery 2005 0.75
160 Early and Late Postoperative Hemorrhage in Moyamoya Angiopathy: Preoperative Predictive Clinical Indicators and Angiographic Correlations: 919. Neurosurgery 2009 0.75
161 Longitudinal Magnetic Resonance Imaging Analysis of a Dose-Escalation Study of Human Embryonic Stem Cell-Derived Human Neural Stem Cells in Experimental Model of Stroke: 964. Neurosurgery 2009 0.75
162 Moyamoya disease can masquerade as multiple sclerosis. Neurologist 2012 0.75
163 Revascularization Surgery in Moyamoya Disease Improves Clinical Disability and Reduces the Incidence of New Transient Ischemic Attack or Stroke 815. Neurosurgery 2006 0.75
164 Internal carotid artery surgical revascularization in a pediatric patient with Schimke immuno-osseous dysplasia. J Neurosurg Pediatr 2014 0.75
165 Complete visual recovery after incipient crao due to ocular hypoperfusion in a patient with moyamoya disease. Retin Cases Brief Rep 2013 0.75
166 Early carotid endarterectomy after ischemic stroke improves diffusion/perfusion mismatch on magnetic resonance imaging: report of two cases. Neurosurgery 2003 0.75
167 Grafts of Neural Precursors Derived from the Basal Forebrain Improve Motor Function in Experimental Stroke 887. Neurosurgery 2006 0.75